European Archives - Page 3 of 1487 - European Medical Journal

Phototherapy Safety In Elderly Psoriasis Patients - EMJ

Phototherapy Remains Effective and Safe in Elderly Psoriasis Patients

Phototherapy shows similar efficacy in elderly and younger psoriasis patients, with fewer side effects in older adults. Read more.

DCCBs and Kidney Risk in Type 2 Diabetes - EMJ

Blood Pressure Drug Linked to Worse Kidney Outcomes in T2D: ERA 2026

New ERA Congress research suggests DCCBs may be linked to worse kidney outcomes in patients with Type 2 diabetes despite standard therapies.

SABR Long Term Renal Cancer Control - EMJ

Stereotactic Radiotherapy Effective in Kidney Cancer

Long-term data from the FASTRACK II trial suggest stereotactic ablative body radiotherapy offers durable local control and a favourable safety profile in patients with primary renal cell carcinoma who are unsuitable for surgery.

Saline Tract Sealing Reduces Pneumothorax risk - EMJ

Saline Tract Sealing Reduces Pneumothorax Risk After Lung Biopsy

Saline tract sealing may reduce the risk of pneumothorax and the need for chest tube placement following CT-guided lung biopsy.

EMJ Rheumatology 13 [Supplement 1] 2026

Want to know what’s shaping the future of osteoporosis care in Europe? Our World Congress on Osteoporosis, Osteoarthritis and…

Improving Fracture Prevention Through Advanced Diagnostic Tools

Fragility fractures represent a major global health burden in patients with osteoporosis, contributing to significant morbidity…

5 Jun 2026

Early DORIS Remission in SLE

Delphi expert consensus guides glucocorticoid tapering in SLE to minimise organ damage while maintaining disease control and improving…

Review of the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) 2026

Organised under the auspices of the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of…

The Musculoskeletal Effects of GLP-1 Therapies

Opening the session, Gülistan Bahat, Istanbul University, Capa, Türkiye, gave a short introduction on how GLP-1 receptor agonists have moved…

Development of Novel Muscle-Active Agents

Sarcopenia is a severe and debilitating disease, affecting muscles and bones, as well as other organs and systems…